For the first-time researchers have identified a blood biomarker to predict the onset of Huntington’s disease, track disease progression and assess the potencies of new therapeutics. Huntington’s Disease (HD) is a fatal progressive neurodegenerative disorder where neurons of basal ganglia of the brain predominantly degenerate. Mutation in huntingtin gene is well demonstrated to cause the disease. The disease symptoms include involuntary limb movements, cognitive decline, and psychiatric changes.
So far, there is no complete cure or way to slow down this disease. The Rather current therapeutic strategy is to reduce the symptoms of HD. Shortcomings of conventional diagnosis: Researchers have long been trying to discover the most cost-effective diagnostic approach for HD. Though brain imaging with MRI/ CT scan or “CAG trinucleotide repeats” detection in huntingtin gene can specifically…
